Literature DB >> 8692416

Cerebral oxygen and glucose metabolism and blood flow in mitochondrial encephalomyopathy: a PET study.

F Shishido1, K Uemura, A Inugami, N Tomura, S Higano, H Fujita, H Sasaki, I Kanno, M Murakami, Y Watahiki, K Nagata.   

Abstract

Cerebral blood flow (CBF), oxygen metabolism (CMRO2), and glucose metabolism (CMRGlc) were measured using positron emission tomography in five patients diagnosed as having mitochondrial encephalomyopathy. The molar ratio between the oxygen and glucose consumptions was reduced diffusely, as CMRO2 was markedly decreased and CMRGlc was slightly reduced. The CBF showed less changes. The CBF increase on hypercapnia was smaller than normal, though this was not significant. CBF with hypocapnia demonstrated a significant reduction compared with the normal. These results suggest that oxidative metabolism is impaired and anaerobic glycolysis relatively stimulated, due to a primary defect of mitochondrial function, and that mild lactic acidosis occurs in brain tissue because of impaired utilisation of pyruvate in the TCA cycle. As these findings appear to indicate directly a characteristic of this disease, such measurements may be a useful tool for assessment of the pathophysiology and for diagnosis of mitochondrial encephalomyopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692416     DOI: 10.1007/bf00604789

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  16 in total

1.  Human cerebral blood flow and oxygen consumption as related to aging.

Authors:  S S KETY
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1956

2.  Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome.

Authors:  P M Matthews; D Tampieri; S F Berkovic; F Andermann; K Silver; D Chityat; D L Arnold
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

3.  Brain metabolism in mitochondrial encephalomyopathy: a PET study.

Authors:  A De Volder; S Ghilain; T de Barsy; A M Goffinet
Journal:  J Comput Assist Tomogr       Date:  1988 Sep-Oct       Impact factor: 1.826

4.  CT and MR of MELAS syndrome.

Authors:  J C Allard; S Tilak; A P Carter
Journal:  AJNR Am J Neuroradiol       Date:  1988 Nov-Dec       Impact factor: 3.825

Review 5.  Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study.

Authors:  S F Berkovic; S Carpenter; A Evans; G Karpati; E A Shoubridge; F Andermann; E Meyer; J L Tyler; M Diksic; D Arnold
Journal:  Brain       Date:  1989-10       Impact factor: 13.501

6.  The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases.

Authors:  R S Frackowiak; S Herold; R K Petty; J A Morgan-Hughes
Journal:  Brain       Date:  1988-10       Impact factor: 13.501

7.  In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF).

Authors:  P M Matthews; S F Berkovic; E A Shoubridge; F Andermann; G Karpati; S Carpenter; D L Arnold
Journal:  Ann Neurol       Date:  1991-04       Impact factor: 10.422

8.  Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.

Authors:  S M Eleff; P B Barker; S J Blackband; J C Chatham; N W Lutz; D R Johns; R N Bryan
Journal:  Ann Neurol       Date:  1990-06       Impact factor: 10.422

9.  Remote effects in MCA territory ischemic infarction: a study of regional cerebral blood flow and oxygen metabolism using positron computed tomography and 15O labeled gases.

Authors:  F Shishido; K Uemura; A Inugami; T Ogawa; T Yamaguchi; I Kanno; M Murakami; K Tagawa; N Yasui
Journal:  Radiat Med       Date:  1987 Mar-Apr

10.  Mitochondrial encephalomyopathy: fluctuating symptoms and CT.

Authors:  T Yamamoto; H Beppu; T Tsubaki
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

View more
  7 in total

1.  MRI estimation of global brain oxygen consumption rate.

Authors:  Varsha Jain; Michael C Langham; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-21       Impact factor: 6.200

2.  Platelet mitochondrial complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism.

Authors:  William J Powers; Richard H Haas; Thuy Le; Tom O Videen; Joanne Markham; Joel S Perlmutter
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-20       Impact factor: 6.200

3.  Separation of cellular and BOLD contributions to T2* signal relaxation.

Authors:  Xialing Ulrich; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2015-03-10       Impact factor: 4.668

4.  The brain is hypothermic in patients with mitochondrial diseases.

Authors:  Mario Rango; Andrea Arighi; Cristiana Bonifati; Roberto Del Bo; Giacomo Comi; Nereo Bresolin
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-12       Impact factor: 6.200

Review 5.  Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches.

Authors:  Dmitriy A Yablonskiy; Alexander L Sukstanskii; Xiang He
Journal:  NMR Biomed       Date:  2012-08-28       Impact factor: 4.044

6.  Vessel-specific quantification of blood oxygenation with T2-relaxation-under-phase-contrast MRI.

Authors:  Lisa C Krishnamurthy; Peiying Liu; Yulin Ge; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668

Review 7.  Monitoring clinical progression with mitochondrial disease biomarkers.

Authors:  Hannah E Steele; Rita Horvath; Jon J Lyon; Patrick F Chinnery
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.